GOLDENBERG CYNTHIA L 5

Accession 0001171843-17-005046

CIK 0000722830other

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:03 PM ET

Size

69.7 KB

Accession

0001171843-17-005046

Insider Transaction Report

Form 5

Period: 2017-06-30

IMMUNOMEDICS INCIMMU

GOLDENBERG CYNTHIA L

DirectorPresident and CEO10% Owner

Transactions

Exercise/Conversion
Common Stock
2017-05-25$3.28/sh+86,500$283,720→ 850,064 total
Exercise/Conversion
Common Stock
2017-05-25$3.28/sh+85,000$278,800→ 850,064 total
Award
Common Stock
2017-01-29+29,240→ 850,064 total
Tax Payment
Common Stock
2017-01-29$4.65/sh−11,696$54,386→ 850,064 total
Tax Payment
Common Stock
2017-01-29$4.65/sh−11,696$54,386→ 5,118,579 total(indirect: See Footnote)
Tax Payment
Common Stock
2017-03-14$6.39/sh−5,848$37,369→ 850,064 total
Award
Common Stock
2017-03-14+14,620→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Common Stock
2017-05-18$3.28/sh+9,500$31,160→ 850,064 total
Sale
Common Stock
2017-05-18$7.38/sh−9,500$70,080→ 850,064 total
Exercise/Conversion
Common Stock
2017-05-19$3.28/sh+9,500$31,160→ 850,064 total
Sale
Common Stock
2017-05-19$7.40/sh−9,500$70,308→ 850,064 total
Exercise/Conversion
Common Stock
2017-05-22$3.28/sh+9,500$31,160→ 850,064 total
Sale
Common Stock
2017-05-22$7.45/sh−9,500$70,783→ 850,064 total
Sale
Common Stock
2017-05-25$7.42/sh−86,500$641,666→ 850,064 total
Exercise/Conversion
Common Stock
2017-05-18$3.28/sh+11,500$37,720→ 5,118,579 total(indirect: See Footnote)
Sale
Common Stock
2017-05-18$7.38/sh−11,500$84,832→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Common Stock
2017-05-19$3.28/sh+11,500$37,720→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Stock Option (right to buy)
2017-05-19−9,500→ 181,000 total
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (9,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-25−86,500→ 85,000 total
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (86,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-25−109,000→ 106,500 total(indirect: See Footnote)
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (109,000 underlying)
Sale
Common Stock
2017-05-19$7.34/sh−11,500$84,426→ 5,118,579 total(indirect: See Footnote)
Award
Common Stock
2017-01-29+29,239→ 5,118,579 total(indirect: See Footnote)
Award
Common Stock
2017-03-14+14,620→ 850,064 total
Tax Payment
Common Stock
2017-03-14$6.39/sh−5,848$37,369→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Stock Option (right to buy)
2017-05-25−85,000→ 0 total
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (85,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-18−11,500→ 238,500 total(indirect: See Footnote)
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (11,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-19−11,500→ 227,000 total(indirect: See Footnote)
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (11,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-25−106,500→ 0 total(indirect: See Footnote)
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (106,500 underlying)
Exercise/Conversion
Common Stock
2017-05-22$3.28/sh+11,500$37,720→ 5,118,579 total(indirect: See Footnote)
Sale
Common Stock
2017-05-22$7.45/sh−11,500$85,730→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Common Stock
2017-05-25$3.28/sh+109,000$357,520→ 5,118,579 total(indirect: See Footnote)
Sale
Common Stock
2017-05-25$7.43/sh−109,000$809,652→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Common Stock
2017-05-25$3.28/sh+106,500$349,320→ 5,118,579 total(indirect: See Footnote)
Exercise/Conversion
Stock Option (right to buy)
2017-05-18−9,500→ 190,500 total
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (9,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-22−9,500→ 171,500 total
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (9,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-05-22−11,500→ 215,500 total(indirect: See Footnote)
Exercise: $3.28Exp: 2017-07-23→ Common Stock, par value $0.01 per share (11,500 underlying)

Footnotes (5)

[F1]Represents the settlement of common stock underlying Performance Units that have vested in accordance with the terms of the Performance-Based Restricted Stock Unit Agreement entered into by and between the Company and the reporting person on August 16, 2013.
[F2]Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer and Chief Patent Officer.
[F3]Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
[F4]The reporting person was granted stock options pursuant to the Company's 2006 Stock Incentive Plan, as amended. Such stock options vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
[F5]The reporting person's spouse, Dr. David M. Goldenberg, was granted stock options pursuant to the Company's 2006 Stock Incentive Plan, as amended. Such stock options vested 25% on the first anniversary of the date grant and 6.25% on a quarterly basis thereafter.

Documents

1 file

5
f5_cynthiagoldenberg081417.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

IMMUNOMEDICS INC

CIK 0000722830

→

Entity typeother

Related Parties

filerCIK 0001202016

Filing Metadata

Form type: 5
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 4:03 PM ET
Size: 69.7 KB

View on SEC.gov